Essam El-Hashani
Overview
Explore the profile of Essam El-Hashani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanteti R, Dhanasingh I, El-Hashani E, Riehm J, Stricker T, Nagy S, et al.
Cancer Biol Ther
. 2015 Nov;
17(1):91-103.
PMID: 26574927
We previously investigated MET and its oncogenic mutants relevant to lung cancer in C. elegans. The inactive orthlogues of the receptor tyrosine kinase Eph and MET, namely vab-1 and RB2088...
2.
Allen M, Kanteti R, Riehm J, El-Hashani E, Salgia R
Nanomedicine
. 2015 Aug;
11(8):1971-4.
PMID: 26282382
From The Clinical Editor: In this interesting article the authors describe a new AFM sampling method to allow better images on whole-animal mounts such as C. elegans. This method would...
3.
Regnier S, El-Hashani E, Kamau W, Zhang X, Massad N, Sargis R
Obesity (Silver Spring)
. 2015 Aug;
23(9):1864-71.
PMID: 26243053
Objective: Environmental endocrine disrupting chemicals (EDCs) are increasingly implicated in the pathogenesis of obesity. Evidence implicates various EDCs as being proadipogenic, including tributyltin (TBT), which activates the peroxisome proliferator activated...
4.
Regnier S, Kirkley A, Ye H, El-Hashani E, Zhang X, Neel B, et al.
Endocrinology
. 2014 Dec;
156(3):896-910.
PMID: 25535829
Environmental endocrine disruptors are implicated as putative contributors to the burgeoning metabolic disease epidemic. Tolylfluanid (TF) is a commonly detected fungicide in Europe, and previous in vitro and ex vivo...
5.
Kanteti R, El-Hashani E, Dhanasingh I, Tretiakova M, Husain A, Sharma S, et al.
BMC Cancer
. 2014 Mar;
14:185.
PMID: 24628993
Background: Non-small cell lung cancers (NSCLC) are highly heterogeneous at the molecular level and comprise 75% of all lung tumors. We have previously shown that the receptor tyrosine kinase (RTK)...
6.
Kanteti R, Krishnaswamy S, Catenacci D, Tan Y, El-Hashani E, Cervantes G, et al.
Genes Chromosomes Cancer
. 2012 May;
51(9):841-51.
PMID: 22585712
RON is a MET related receptor tyrosine kinase (RTK) and its natural ligand is macrophage stimulating protein (MSP). RON plays a very important role in the regulation of inflammation. Several...
7.
Catenacci D, Cervantes G, Yala S, Nelson E, El-Hashani E, Kanteti R, et al.
Cancer Biol Ther
. 2011 May;
12(1):9-46.
PMID: 21543897
RON (MST1R) is one of two members of the MET receptor tyrosine kinase family, along with parent receptor MET. RON has a putative role in several cancers, but its expression...
8.
Loganathan S, Kanteti R, Siddiqui S, El-Hashani E, Tretiakova M, Vigneswaran H, et al.
J Carcinog
. 2011 Mar;
10:4.
PMID: 21383961
Purpose: To examine the role of both protein kinase C (PKC)-β and vascular endothelial growth factor receptor (VEGFR)-2 in malignant pleural mesothelioma (MPM) using respective inhibitors, enzastaurin and KRN633. Materials...
9.
Tan Y, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, et al.
PLoS One
. 2010 Feb;
5(1):e8972.
PMID: 20126411
Background: Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations. c-CBL is an E3 ubiquitin ligase and adaptor molecule important...
10.
Faoro L, Cervantes G, El-Hashani E, Salgia R
J Thorac Oncol
. 2009 Oct;
4(11 Suppl 3):S1064-5.
PMID: 19861919
No abstract available.